Minimally Invasive and Robotic Surgery for Rectal Cancer

Area of Science:

• Oncology
• Surgical Innovation
• Gastrointestinal Surgery

Background:

• Rectal cancer management has shifted from surgery alone to multimodal therapeutic approaches.
• Dr. Heald's total mesorectal excision significantly improved surgical outcomes, reducing recurrence and enhancing survival and quality of life.
• Minimally invasive surgical techniques are increasingly adopted for rectal cancer treatment.

Purpose of the Study:

• To review the evolution of rectal cancer treatment, focusing on surgical advancements.
• To evaluate the oncologic outcomes and patient benefits of minimally invasive rectal cancer surgery.
• To discuss the current role and future potential of laparoscopic and robotic surgery in rectal cancer care.

Main Methods:

• Review of historical surgical techniques and their impact on rectal cancer outcomes.
• Analysis of randomized controlled trials comparing laparoscopic versus open surgery for rectal cancer.
• Evaluation of emerging evidence on robotic surgery for rectal cancer treatment.

Main Results:

• Total mesorectal excision (TME) is a cornerstone of modern rectal cancer surgery.
• Laparoscopic surgery for rectal cancer demonstrates oncologic outcomes comparable to open surgery.
• Robotic surgery presents potential advantages, though further research is ongoing.

Conclusions:

• Minimally invasive surgical approaches, including laparoscopy and robotic surgery, are becoming standard-of-care for select rectal cancer patients.
• These techniques offer potential benefits in recovery and quality of life alongside oncologic efficacy.
• Continued research and technological advancements will further refine surgical management of rectal cancer.